What if there was a way to offer patients living with diabetes a way to take their medication without having to puncture their skin for each shot? A tool that allows a patient on multiple daily injections (MDI) who’s taking an average of five shots per day to reduce that number from 150 to 10 in just 1 month? That’s 93% less pokes! Guess what? There is and it’s called the i-Port AdvanceTM injection port.
The i-Port AdvanceTM injection port is a small and discrete patch that sticks to the user’s skin, similar to an adhesive bandage. It can be worn on the abdomen, upper thighs, back of the arms, hips, and upper buttocks for up to three days and is safe to use during activities such as exercising, sleeping, and even bathing.
The insertion process is also simple. The i-Port AdvanceTM injection port includes a built-in inserter, which enables a quick and virtually painless1 application. Once inserted, only a soft flexible tube, called a cannula, remains under the skin allowing for direct medication delivery from an insulin syringe or an insulin pen into the subcutaneous tissue. If you’re familiar with insulin pump infusion sets, consider this similar to an infusion set without tubing.
Patients newly diagnosed with type 1 or type 2 diabetes who are new to taking insulin, may benefit the most from using the i-Port AdvanceTM injection port as this may facilitate the transition to MDI. Those who experience the emotional challenges of taking injections such as fear, anxiety, and stress or even the physical impact of shots like bruising, scarring, or pain may also benefit from using the i-Port AdvanceTM injection port. In fact, in a patient survey: 98% reported thinking it was comfortable to wear, 99% said it was more beneficial than injections, and 100% reported that it helped decrease anxiety2.
To learn more about the iPort AdvanceTM injection port and how it can help patients experience less pain and more comfort, click here. And as always, feel free to reach out to your local Medtronic Field Representative for additional information.
Hanas R, Adolfsson P, Elfvin-Akesson K et al. Indwelling catheters used from the onset of diabetes decrease injection pain and pre-injection anxiety. J Pediatr. 2002;140(3)315-320
Riley D, Raup G. Impact of a subcutaneous injection device on improving patient care. Nurs Manage. 2010;41(6):49-54